1. Rivers EP. Early goal-directed therapy in severe sepsis and septic shock: converting science to reality. Chest. 2006;129:217–218.
2. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 2002 emergency department summary. Adv Data. 2004;340:1–34.
3. Angus D, Linde-Zwirble WT, Lidicker MA, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310.
4. Wang H, Shapiro N, Angus D, et al. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35:1928–1936.
5. Zambon M, Ceola M, Almeida-de-Castro R, et al. Implementation of the surviving sepsis campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care. 2008;23:455–460.
6. Bone RC, Balk RA, Cerra FB, et al. The American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–1655.
7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250–1256.
8. Marshall JC, Vincent JL, Fink MP, et al. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable. Crit Care Med. 2003;31:1560–1567.
9. Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and c-reactive protein as markers of sepsis. Crit Care Med. 2003;31:1737–1741.
10. Shapiro NI, Trzeciak S, Hollander JE, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009;37:96–104.
11. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;(38):367–374.
13. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009;37:1670–1677.
14. Berkman M, Ufberg J, Nathanson LA, Shapiro NI. Anion gap as a screening tool for elevated lactate in patients with an increased risk of developing sepsis in the emergency department. J Emerg Med. 2009;36:391–394.
15. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32: 1637–1642.
16. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596.
17. Larche J, Azoulay E, Fieux F, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–1695.
18. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC). EPIC International Advisory Committee. JAMA. 1995;274:639–644.
19. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.
20. Leone M, Perrin AS, Granier I, et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med. 2007;33:726–729.
21. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–1321.
22. Carunta FA, Benea L. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, treatment. J Gastrointest Liver Dis. 2006;15:51–56.
23. Elliott DC, Kufera JA, Myers RA, et al. The microbiology of necrotizing soft tissue infections. Am J Surg. 2000; 179:361–366.
24. Arabi Y, Memish ZA, Balkhy Y, HH, et al. Ventriculostomy associated infections: incidence and risk factors. Am J Infect Control. 2005;33:137–143.
25. Marshall JC, al Naqbi A. Principles of source control in the management of sepsis. Crit Care Clin. 2009;25:753–768, viii–ix.
26. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946–955.
27. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32:S451–S454.
28. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of
albumin and saline for fluid resuscitation in the intensive care unit.
N Engl J Med. 2004;350:2247–2256.
29. Brunkhorst FM, Engel C, Bloos F, et al. Intensive
insulin therapy and
pentastarch resuscitation in severe sepsis.
N Engl J Med. 2008;358:125–139.
30. Wiedermann CJ. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med. 2008;8:1.
31. Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol. 2008;214:211–223.
32. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med. 2006;34:1333–1337.
33. Rivers EP. Fluid-management strategies in acute lung injury—liberal, conservative, or both? N Engl J Med. 2006;354(24):2598–2600.
34. Wiedemann HP, Wheeler AP, Bernard GR, et al. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid management strategies in acute lung injuries. N Engl J Med. 2006;354(24):2564–2575. Epub May 21, 2006.
35. Levy MM, Macias WL, Vincent JL, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med. 2005;33(10):2194–2201.
36. Landry DW, Levin HR, Gallant EM, et al. Vasodilation deficiency contributes to the vasodilatation of septic shock. Circulation. 1997;95:1122–1125.
37. Morgenthaler NG, Struck J, Alonso C, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of
vasopressin. Clin Chem. 2006;52:112–119.
38. Marini JJ, Wheeler AP, eds. Critical Care Medicine: The Essentials. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
39. Martin C, Viviand X, Leone M, Thirion X. Effect of
norepinephrine on the outcome of septic shock.
Crit Care Med. 2000;28:2758–2765.
40. Marik PE, Mohedin M. The contrasting effects of
dopamine and
norepinephrine on systemic and splanchnic
oxygen utilization in hyperdynamic sepsis.
JAMA. 1994;272:1354–1357.
41. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588–595.
42. Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32:S455–S465.
43. Jakob S. Clinical review: splanchnic ischaemia. Crit Care. 2002;6:306–312.
44. Sakr Y, Reinhart K, Vincent JL, et al. Does
dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
Crit Care Med. 2006;34:589–597.
45. Parrillo JE, Dellinger RP, eds. Critical Care Medicine: Principles of Diagnosis and Management in the Adult. 3rd ed. Philadelphia: Mosby Elsevier; 2008.
46. De Backer D, Creteur J, Silva E, Vincent JL. Effects of
dopamine,
norepinephrine, and
epinephrine on the splanchnic circulation in septic shock: which is best?
Crit Care Med. 2003;31:1659–1667.
47. Levy B. Use of pressors in the management of septic shock. Lancet. 2007;370:1827. Author reply 8.
48. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.
49. Landry DW, Levin HR, Gallant EM, et al.
Vasopressin deficiency contributes to the vasodilation of septic shock.
Circulation. 1997;95:1122–1125.
50. Ertmer C, Morelli A, Bone HG, et al.
Dobutamine reverses the vasopressin-associated impairment in cardiac index and systemic
oxygen supply in ovine endotoxemia.
Crit Care. 2006;10:R144.
51. Russell JA, Walley KR, Singer J, et al.
Vasopressin versus
norepinephrine infusion in patients with septic shock.
N Engl J Med. 2008;358:877–887.
52. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377.
53. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333(16): 1025–1032.
54. Chawla LS, Zia H, Gutierrez G, et al. Lack of equivalence between central and mixed venous
oxygen saturation.
Chest. 2004;126(6):1891–1896.
55. Tamion F, Le Cam-Duchez V, Menard JF, et al. Serum erythropoietin levels in septic shock. Anaesth Intensive Care. 2005;33(5):578–584.
56. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335:1206–1212.
57. Lefering R, Neugebauer E. Steroid controversy in sepsis and septic shock: a met analysis. Crit Care Med. 1995;23:1294–1303.
58. Sprung CL, Caralis PV, Marcial EH, et al. The effect of high-dose corticosteroids in patients with septic shock. N Engl J Med. 1984;311:1137–1143.
59. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of
hydrocortisone and
fludrocortisone on mortality in patients with septic shock.
JAMA. 2002;288:862–871.
60. Sprung CL, Annane D, Keh D, et al.
Hydrocortisone therapy for patients with septic shock.
N Engl J Med. 2008;358:111–124.
61. Sakles JC, Laurin EG, Rantapaa AA, et al. Airway management in the emergency department: a one-year study of 610 tracheal intubations. Ann Emerg Med. 1998;31: 325–332.
62. Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anesthesia. 1984;39:973–981.
63. Wagner RL, White PF, Kan PB, et al. Inhibition of adrenal steroidogenesis by the anesthetic
etomidate.
N Engl J Med. 1984;310:1415–1421.
64. Benard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.
65. Fourrier F. Recombinant human activated protein C in the treatment of severe sepsis: an evidence based review. Crit Care Med. 2004;32(S):S434–S441.
66. Yan SB, Helterbrand JD, Hartman DL, et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest. 2001;120:915–922.
67. Vincent JL, Bernard GR, Beale R, et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med. 2005;33:2266–2277.
68. Bernard GR, Artigas A, Brigham KL, et al. The American–European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824.
69. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308.
70. Van den Berghe G, Wouters P, Weekers F, et al. Intensive
insulin therapy in critically ill patients.
N Engl J Med. 2001;345:1359–1367.
71. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive
insulin therapy in the medical ICU.
N Engl J Med. 2006;354:449–461.
72. Rivers EP, Coba V, Whitmill M. Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature. Curr Opin Anaesthesiol. 2008;21:128–140.
73. Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care. 2005;9:R764–R770.
74. Huang DT, Angus DC, et al. Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock. Crit Care. 2003;7:S116.
75. Shapiro NI, Howell MD, Talmor D, et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med. 2006;34(4):1025–1032.
76. Trzeciak S, Dellinger RP, Abate NL, et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest. 2006;129(2): 225–232.
77. Frank ED. A shock team in a general hospital. Anesth Analg. 1967;46(6):740–745.